Diametric Capital’s 89bio ETNB Stock Holding History

Diametric Capital’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,029	Closed	-$214K	–	390
2023 Q1	$214K	Buy	+14,029	New	+$183K	0.1%	228

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Diametric Capital's ETNB Position: Q2 2023 in Review

Diametric Capital sold out of 89bio (ETNB) in Q2 2023, closing a stake of 14,029 shares — an estimated $214K sold.

Diametric Capital first reported a position in ETNB in Q1 2023 and held it in 1 quarter. The position peaked at $214K in Q1 2023. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

Diametric Capital reported no remaining 89bio position as of Q2 2023 after selling out during the quarter.
Diametric Capital sold 14,029 89bio shares in Q2 2023, an estimated $214K.
Diametric Capital first reported a position in 89bio in Q1 2023 and held it in 1 quarter.
Diametric Capital's 89bio position peaked at $214K in Q1 2023.
157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on Diametric Capital's 13F filing for Q2 2023, filed 11 Aug 2023.